Protagonist Therapeutics Eulerpool Novinky

Protagonist Therapeutics Novinky o akciích

Protagonist Therapeutics je sledován mnoha novináři a investory po celém světě. Nejaktuálnější Protagonist Therapeutics zprávy shromažďujeme zde.

• 21. července ·

  Yahoo
  Protagonist Announces Submission of NDA for First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis
• 14. července ·

  Yahoo
  Exploring 3 High Growth Tech Stocks In The US Market
• 29. června ·

  SeekingAlpha
  Top Forensic Value Mid-Year 2025 Selections: Highest Positive And Negative Scoring Stocks For July
• 26. června ·

  Yahoo
  Protagonist Therapeutics to Host Conference Call to Announce an Oral Obesity Development Candidate
• 24. června ·

  Yahoo
  Protagonist Therapeutics, Takeda Pharmaceutical Announce Positive Phase 3 Rusfertide Results for Polycythemia Vera
• 20. června ·

  Yahoo
  Citi Rates Protagonist Therapeutics (PTGX) as Buy Protagonists Drugs Opportunity
• 20. června ·

  SeekingAlpha
  Protagonist Therapeutics: Two 'Slam Dunk' Sets Of Pivotal Data Set Up Bull Case
• 9. června ·

  SeekingAlpha
  ASCO 2025: Profiling The Biggest Presentations At The Biggest Cancer Meeting
• 5. června ·

  Yahoo
  Exploring Three High Growth Tech Stocks In The US Market
• 1. června ·

  Yahoo
  Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia Vera